Influence of single nucleotide polymorphisms among cigarette smoking and non-smoking patients with coronary artery disease, urinary bladder cancer and lung cancer
Autor: | Freddi Lewin, Levar Shamoun, Jan-Erik Karlsson, Bengt-Åke Andersson, Magnus Kentsson, Sture Löfgren, Shariel Sayardoust, Lars Erik Rutqvist, David Robinsson, Matida Fagerberg, Mats Nilsson, Nongnit Laytragoon Lewin |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Male
Lung Neoplasms Pulmonology Epidemiology Single Nucleotide Polymorphisms medicine.medical_treatment Social Sciences Coronary Artery Disease Disease Cardiovascular Medicine Vascular Medicine Lung and Intrathoracic Tumors Suppressor Genes Coronary artery disease Habits XRCC1 Medical Conditions Smoking Habits Medicine and Health Sciences Psychology Coronary Heart Disease Public and Occupational Health Cardiac and Cardiovascular Systems Multidisciplinary Kardiologi Cancer Risk Factors Middle Aged Oncology Cardiovascular Diseases Medicine Female Research Article medicine.medical_specialty Substance-Related Disorders Tumor Suppressor Genes Science Cardiology Single-nucleotide polymorphism Polymorphism Single Nucleotide Cigarette Smoking Respiratory Disorders Gene Types Internal medicine Mental Health and Psychiatry Genetics medicine Humans SNP Genetic Predisposition to Disease Risk factor Lung cancer Aged Behavior business.industry Biology and Life Sciences Smoking Related Disorders Cancers and Neoplasms Human Genetics medicine.disease Urinary Bladder Neoplasms Case-Control Studies Medical Risk Factors Smoking cessation business |
Zdroj: | PLoS ONE, Vol 16, Iss 1, p e0243084 (2021) PLoS ONE |
Popis: | Introduction Cigarette smoke is suggested to be a risk factor for coronary artery disease (CAD), urinary bladder cancer (UBCa) or lung cancer (LCa). However, not all heavy smokers develop these diseases and elevated cancer risk among first-degree relatives suggests an important role of genetic factor. Methods Three hundred and ten healthy blood donors (controls), 98 CAD, 74 UBCa and 38 LCa patients were included in this pilot study. The influence of 92 single nucleotide polymorphisms (SNPs) and impact of cigarette smoking were analysed. Results Out of 92 SNPs tested, differences in distribution of 14 SNPs were detected between controls and patient groups. Only CTLA4 rs3087243 showed difference in both CAD and UBCa patient group compared to control group. Stratified by smoking status, the impact of smoking was associated to frequencies of 8, 3 and 4 SNPs in CAD, UBCa, LCa patients, respectively. None of these 92 SNPs showed a statistically significant difference to more than one type of disease among smoking patients. In non-smoking patients, 7, 3 and 6 SNPs were associated to CAD, UBCa, LCa, respectively. Out of these 92 SNPs, CTLA4 rs3087243 was associated to both non-smoking CAD and UBCa. The XRCC1 rs25487 was associated to both non-smoking UBCa and LCa. Conclusion SNPs might be important risk factors for CAD, UBCa and LCa. Distribution of the SNPs was specific for each patient group, not a random event. Impact of cigarette smoking on the disease was associated to the specific SNP sequences. Thus, smoking individuals with SNPs associated to risk of these serious diseases is an important target group for smoking cessation programs. |
Databáze: | OpenAIRE |
Externí odkaz: |